Benzinga | Jun 8, 2021 08:35AM EDT

Evoke Pharma Announces FDA Orange Book Listing Of US Patent For Gimoti

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that its US patent No. 11,020,361 for Gimoti(r) (metoclopramide) nasal spray is now listed in the U.S. Food and Drug Administration (FDA) publication, "Approved Drug Products with Therapeutic Equivalence Evaluations", commonly known as the "Orange Book". The patent covers methods of use for nasal delivery of metoclopramide for the treatment of gastroparesis.